Sorafenib Treatment Modalities for Hepatocellular Carcinoma Patients in Italy

Trial Profile

Sorafenib Treatment Modalities for Hepatocellular Carcinoma Patients in Italy

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms STELLA
  • Sponsors Bayer
  • Most Recent Events

    • 19 Oct 2016 Results (n=512) of a pooled analysis from the Italian subgroup of GIDEON and from STELLA study assessing safety and efficacy in clinical practice, presented at the 24th United European Gastroenterology Week
    • 29 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 04 Mar 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top